Clinical Trial Update: IntellO2 vs Manual Control for Optimizing Oxygenation in Infants [NA]

View source ↗

Summary

A completed clinical trial comparing the IntellO2 oxygen titration system to manual control for optimizing oxygenation in preterm infants with lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Lung Disease of Prematurity
• Respiratory Distress Syndrome of Newborn

Drugs mentioned

• IntellO2

Snippet

Sponsor: Vapotherm, Inc. | Conditions: Oxygen Titration in Preterm Infants to Manage Lung Disease | NA | Status: COMPLETED